SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Huaizhong Health Group, Inc. (ADAD) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分: 16/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — ADAD
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2013 |
$0.00 |
$0.00 |
$-72.00 |
- |
| 2014 |
$90.89 |
$91.31K |
$22.72K |
24.9% |
| 2015 |
$-153.15 |
$105.84K |
$-47.78K |
-45.1% |
| 2016 |
$2.46 |
$41.63K |
$866.00 |
2.1% |
| 2017 |
$-0.60 |
$40.51K |
$-78.13K |
-192.9% |
| 2018 |
$-0.02 |
$20.55K |
$-6.37K |
-31% |
| 2019 |
$-0.41 |
$20.55K |
$-126K |
-613% |
| 2020 |
$0.00 |
$0.00 |
$-36.48K |
- |
| 2021 |
$0.00 |
$0.00 |
$-30.83K |
- |
| 2022 |
$0.00 |
$0.00 |
$-29.17K |
- |